DOCSLIB.ORG

Genomewide Transcriptional Changes Associated with Genetic Alterations and Nutritional Supplementation Affecting Tryptophan Metabolism in Bacillus Subtilis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genomewide Transcriptional Changes Associated with Genetic Alterations and Nutritional Supplementation Affecting Tryptophan Metabolism in Bacillus Subtilis Genomewide transcriptional changes associated with genetic alterations and nutritional supplementation affecting tryptophan metabolism in Bacillus subtilis Randy M. Berka*, Xianju Cui*, and Charles Yanofsky†‡ *Novozymes Biotech, Inc., Davis, CA 95616; and †Department of Biological Sciences, Stanford University, Stanford, CA 94305 Contributed by Charles Yanofsky, March 19, 2003 DNA microarrays comprising Ϸ95% of the Bacillus subtilis anno- initiation at the trp operon promoter͞operator. Transcription tated protein coding ORFs were deployed to generate a series of initiation is not known to be regulated at the trp operon snapshots of genomewide transcriptional changes that occur when promoter of B. subtilis. Transcription of the structural genes in cells are grown under various conditions that are expected to the trp operons of both organisms is regulated by transcription increase or decrease transcription of the trp operon segment of the attenuation, but by different mechanisms. In B. subtilis a tryp- aromatic supraoperon. Comparisons of global expression patterns tophan-activated RNA-binding protein (TRAP), the product of were made between cells grown in the presence of indole acrylic the mtrB gene, regulates attenuation. The mtrB coding sequence acid, a specific inhibitor of tRNATrp charging; cells deficient in resides in a two-gene operon with mtrA, which specifies GTP expression of the mtrB gene, which encodes the tryptophan- cyclohydrolase I, the enzyme catalyzing the first step in pterin activated negative regulatory protein, TRAP; WT cells grown in the formation in folic acid biosynthesis. In addition to these aro- presence or absence of two or three of the aromatic amino acids; matic-folate cross-pathway features, at least one additional and cells harboring a tryptophanyl tRNA synthetase mutation operon, rtpA-ycbK, appears to play an important regulatory role conferring temperature-sensitive tryptophan-dependent growth. in trp operon expression in B. subtilis (4, 5). Transcription of Our findings validate expected responses of the tryptophan bio- rtpA-ycbK is regulated by the T box antitermination mechanism synthetic genes and presumed regulatory interrelationships be- in response to a deficiency of charged tRNATrp (4, 6). Expression tween genes in the different aromatic amino acid pathways and of the rtpA-ycbK operon leads to the synthesis of the anti-TRAP the histidine biosynthetic pathway. Using a combination of super- regulatory protein AT, the rtpA gene product (5). AT can vised and unsupervised statistical methods we identified Ϸ100 inactivate TRAP and when it does this allows trp operon genes whose expression profiles were closely correlated with transcription and trpG translation. AT production is also regu- those of the genes in the trp operon. This finding suggests that lated translationally, in response to the accumulation of un- expression of these genes is influenced directly or indirectly by charged tRNATrp (G. Chen and C.Y., unpublished data). Many regulatory events that affect or are a consequence of altered of the known B. subtilis genes that are presumed to play a role tryptophan metabolism. in aromatic amino acid metabolism and folic acid synthesis and regulation are presented in Fig. 1. omologous protein domains are used by Bacillus subtilis and B. subtilis also lacks a structural homolog of TyrR, the major HEscherichia coli to catalyze the same reactions in the regulatory protein of E. coli that controls expression of the biosynthesis of the aromatic amino acids (1). Despite this common aromatic pathway genes and the genes required for similarity, very different regulatory proteins and mechanisms are phenylalanine and tyrosine synthesis. However, some of these B. used by these bacteria to regulate aromatic amino acid synthesis. subtilis genes are regulated in response to tyrosine or phenylal- These differences must be partly caused by the different evolu- anine accumulation. In addition, in B. subtilis, a single gene, tionary histories and experiences of these microorganisms. aroA, specifies 3-deoxy-D-arabino-heptulosonate-7-phosphate Operon organization also is somewhat different in the two (DAHP) synthase, the enzyme that catalyzes the first step in the species, reflecting regulatory interrelationships described as common aromatic pathway. Synthesis of this enzyme is regulated cross-pathway control, that exist between genes for different only indirectly by aromatic amino acids (1, 3). E. coli produces pathways in B. subtilis that are not evident in E. coli. Thus, the three nearly identical DAHP synthases that catalyze this reac- six-gene trp operon of B. subtilis resides within an aromatic tion, and each is subject to transcriptional regulation principally supraoperon that contains six additional genes, three upstream by a different aromatic amino acid. and three downstream, concerned with the common aromatic The present study parallels a similar investigation of E. coli pathway and with phenylalanine, tyrosine, and histidine biosyn- genes that respond transcriptionally to culture conditions and thesis (Fig. 1). The seventh trp gene, trpG (pabA), is in the folate genetic alterations that influence tryptophan metabolism (7). operon. This gene specifies a protein that functions both in Herein we describe the application of B. subtilis DNA microar- tryptophan and folate biosynthesis; presumably because of this, rays as an initial step toward our goal of determining the global it is subject to regulation by both metabolites. In E. coli the effects on gene expression of varying tryptophan and charged five-gene trp operon encodes all seven protein domains needed tRNATrp availability in B. subtilis. for tryptophan biosynthesis; two of these genes encode fused protein domains that engender bifunctional polypeptides (2). Materials and Methods The B. subtilis aromatic supraoperon has three promoters as B. subtilis Strains. The following B. subtilis strains were used in shown in Fig. 1 (1, 3). One promoter is located before the three these studies: CYBS400 (WT) (4), CYBS222 (mtrBϪ) [a frame- genes upstream of the six-gene trp operon. A second promoter shift mutation located near the end of the mtrB coding region immediately precedes the trp operon segment. These two pro- yields a TRAP protein with reduced activity (3)], and BS1A353 moters provide trp operon transcripts. The third supraoperon promoter is within trpA, the last trp gene; it provides transcripts derived from the last three genes of the supraoperon. A major Abbreviations: TRAP, tryptophan-activated RNA-binding protein; PC, principal compo- regulatory difference between E. coli and B. subtilis is that E. coli nent; PCA, PC analysis. uses a DNA-binding repressor protein to control transcription ‡To whom correspondence should be addressed. E-mail: [email protected]. 5682–5687 ͉ PNAS ͉ May 13, 2003 ͉ vol. 100 ͉ no. 10 www.pnas.org͞cgi͞doi͞10.1073͞pnas.1031606100 Downloaded by guest on September 24, 2021 Table 1. B. subtilis cells and growth conditions used as sources of RNA for microarray studies Experiment B. subtilis strains and culture conditions Replicates* 1 WT in minimal medium versus WT in 8 minimal ϩ 50 ␮g͞ml tryptophan WT grown in minimal medium ؉ 30 ␮g͞ml 6 2 indole acrylic acid versus WT grown in minimal medium 3 mtrB-deficient mutant grown in minimal 8 medium ؉ 50 ␮g͞ml tryptophan versus WT grown in minimal medium ϩ 50 ␮g͞ml tryptophan 4 WT grown in minimal medium with 50 5 ␮g͞ml each phenylalanine and tyrosine versus WT grown in minimal medium 5 WT grown in minimal medium versus WT 7 grown in minimal medium with 50 ␮g͞ml Fig. 1. Known relationships among the genes of the aromatic supraoperon. each tryptophan, phenylalanine, and Colored lines connect the genes that are directly responsible for synthesis of tyrosine tryptophan (red), folate (blue), histidine (green), phenylalanine (gray), cho- 6 WT grown in minimal medium with 50 7 rismate (violet), and tyrosine (brown). Promoters are denoted by PЈ. Orange ␮g͞ml each phenylalanine and tyrosine rectangles represent leader regulatory regions controlled by tRNA-mediated versus WT grown in minimal medium antitermination, and gray boxes define regions at which TRAP (mtrB gene with 50 ␮g͞ml each tryptophan, product) binds and regulates translation. The promoter of the trp operon phenylalanine, and tyrosine itself (trpEDCFBA) is denoted as a violet box because TRAP regulates tran- ts scription at this site. Anti-TRAP (rtpA gene product) forms a complex with 7 trpS1 mutant grown at 38°C in minimal 8 ؉ TRAP and inhibits its activity and is noted as AT. medium 0.2% acid hydrolyzed casein ؉ 50 ␮g͞ml tryptophan versus WT grown in the same medium (trpS1), a mutation in the tryptophanyl-tRNA synthetase struc- To minimize intensity biases that are sometimes observed with the use of tural gene resulting in temperature-sensitive tryptophan- Cy3͞Cy5 dyes we used a dye-swapping strategy for some of the experiments dependent growth (8). listed. Consequently, the fluorescence intensity ratios were calculated as the intensity derived from one cDNA probe (growth condition or strain) divided by Culture Conditions and Isolation of RNA. Cultures (50 ml) were the other. The inducing condition, indicated in boldface type, corresponds to grown to midlog phase with shaking in minimal medium (9) plus the cells indicated by * in Table 2. The term “replicates” as used here refers to trace elements, plus and minus various supplements, at 37°C. the number of times the B. subtilis genome was queried with fluorescently
Load more

Recommended publications
  • Chapter 18 Regulation of Gene Expression Regulation of Gene Expression • Important for Cellular Control and Differentiation
    Chapter 18 Regulation of Gene Expression Regulation of Gene Expression • Important for cellular control and differentiation. • Understanding “expression” is a “hot” area in Biology. General Mechanisms 1. Regulate Gene Expression 2. Regulate Protein Activity Operon Model • Jacob and Monod (1961) - Prokaryotic model of gene control. • Always on the National AP Biology exam! Operon Structure 1. Regulatory Gene 2. Operon Area a. Promoter b. Operator c. Structural Genes Gene Structures Regulatory Gene • Makes Repressor Protein which may bind to the operator. • Repressor protein blocks transcription. Promoter • Attachment sequence on the DNA for RNA polymerase to start transcription. Operator • The "Switch”, binding site for Repressor Protein. • If blocked, will not permit RNA polymerase to pass, preventing transcription. Structural Genes • Make the enzymes for the metabolic pathway. Lac Operon • For digesting Lactose. • Inducible Operon - only works (on) when the substrate (lactose) is present. If no Lactose • Repressor binds to operator. • Operon is "off”, no transcription, no enzymes made If Lactose is absent If Lactose is present • Repressor binds to Lactose instead of operator. • Operon is "on”, transcription occurs, enzymes are made. If Lactose is present Enzymes • Digest Lactose. • When enough Lactose is digested, the Repressor can bind to the operator and switch the Operon "off”. Net Result • The cell only makes the Lactose digestive enzymes when the substrate is present, saving time and energy. Animation • http://www.biostudio.com/d_%20Lac%20Ope ron.htm trp Operon • Makes/synthesizes Tryptophan. • Repressible Operon. – Predict how it is different from the inducible operon… If no Tryptophan • Repressor protein is inactive, Operon "on” Tryptophan made. • “Normal” state for the cell.
    [Show full text]
  • Consensus Guideline for the Diagnosis and Treatment of Aromatic L-Amino
    Wassenberg et al. Orphanet Journal of Rare Diseases (2017) 12:12 DOI 10.1186/s13023-016-0522-z REVIEW Open Access Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency Tessa Wassenberg1, Marta Molero-Luis2, Kathrin Jeltsch3, Georg F. Hoffmann3, Birgit Assmann3, Nenad Blau4, Angeles Garcia-Cazorla5, Rafael Artuch2, Roser Pons6, Toni S. Pearson7, Vincenco Leuzzi8, Mario Mastrangelo8, Phillip L. Pearl9, Wang Tso Lee10, Manju A. Kurian11, Simon Heales12, Lisa Flint13, Marcel Verbeek1,14, Michèl Willemsen1 and Thomas Opladen3* Abstract Aromatic L-amino acid decarboxylase deficiency (AADCD) is a rare, autosomal recessive neurometabolic disorder that leads to a severe combined deficiency of serotonin, dopamine, norepinephrine and epinephrine. Onset is early in life, and key clinical symptoms are hypotonia, movement disorders (oculogyric crisis, dystonia, and hypokinesia), developmental delay, and autonomic symptoms. In this consensus guideline, representatives of the International Working Group on Neurotransmitter Related Disorders (iNTD) and patient representatives evaluated all available evidence for diagnosis and treatment of AADCD and made recommendations using SIGN and GRADE methodology. In the face of limited definitive evidence, we constructed practical recommendations on clinical diagnosis, laboratory diagnosis, imaging and electroencephalograpy, medical treatments and non-medical treatments. Furthermore, we identified topics for further research. We believe this guideline will improve the care for AADCD patients around the world whilst promoting general awareness of this rare disease. Keywords: Aromatic l-amino acid decarboxylase deficiency, AADC deficiency, Neurotransmitter, Dopamine, Serotonin, Guideline, Infantile dystonia-parkinsonism, SIGN, GRADE German abstract Der Aromatische L-Aminosäuren Decarboxylase Mangel (AADCD) ist eine seltene autosomal rezessive neurometabolische Störung, die zu einem schweren kombinierten Mangel an Serotonin, Dopamin, Norepinephrin und Epinephrin führt.
    [Show full text]
  • RNA-Based Regulation of Genes of Tryptophan Synthesis and Degradation, in Bacteria
    REVIEW RNA-based regulation of genes of tryptophan synthesis and degradation, in bacteria CHARLES YANOFSKY Department of Biological Sciences, Stanford University Stanford, California 94305, USA ABSTRACT We are now aware that RNA-based regulatory mechanisms are commonly used to control gene expression in many organisms. These mechanisms offer the opportunity to exploit relatively short, unique RNA sequences, in altering transcription, translation, and/or mRNA stability, in response to the presence of a small or large signal molecule. The ability of an RNA segment to fold and form alternative hairpin secondary structures—each dedicated to a different regulatory function—permits selection of specific sequences that can affect transcription and/or translation. In the present paper I will focus on our current understanding of the RNA-based regulatory mechanisms used by Escherichia coli and Bacillus subtilis in controlling expression of the tryptophan biosynthetic operon. The regulatory mechanisms they use for this purpose differ, suggesting that these organisms, or their ancestors, adopted different strategies during their evolution. I will also describe the RNA-based mechanism used by E. coli in regulating expression of its operon responsible for tryptophan degradation, the tryptophanase operon. Keywords: trp operon; trp suboperon; aro supraoperon; tna operon; transcription attenuation; T box regulation; tryptophan as a regulatory signal; tRNATrp as a regulatory signal; peptidyl-tRNA; ribosome mediated regulation INTRODUCTION A second regulatory lesson learned over the years is that information within mRNAs, or other RNAs, as well as small Studies over the past 50+ years have revealed that metabolites and other molecules—in addition to DNA and optimization of gene expression has been a major evolu- proteins—often provides specific regulatory signals, or tionary objective for most species.
    [Show full text]
  • Plasma Amino-Acid Patterns in Liver Disease
    Gut: first published as 10.1136/gut.23.5.362 on 1 May 1982. Downloaded from Gut, 1982, 23, 362-370 Plasma amino-acid patterns in liver disease MARSHA Y MORGAN*, A W MARSHALL, JUDITH P MILSOM, and SHEILA SHERLOCK From the Department of Medicine, Royal Free Hospital, London SUMMARY Plasma amino-acid concentrations were measured in 167 patients with liver disease of varying aetiology and severity, all free of encephalopathy, and the results compared with those in 57 control subjects matched for age and sex. In the four groups of patients with chronic liver disease (26 patients with chronic active hepatitis, 23 with primary biliary cirrhosis, 11 with cryptogenic cirrhosis, and 48 with alcoholic hepatitis±cirrhosis) plasma concentrations of methionine were significantly increased, while concentrations of the three branched chain amino-acids were significantly reduced. In the first three groups of patients plasma concentrations of aspartate, serine, and one or both of the aromatic amino-acids tyrosine and phenylalanine were also significantly increased, while in the patients with alcoholic hepatitis±cirrhosis plasma concentrations of glycine, alanine, and phenylalanine were significantly reduced. In the three groups of patients with minimal, potentially reversible liver disease (31 patients with alcoholic fatty liver, 10 with viral hepatitis, and 18 with biliary disease) plasma concentrations of proline and the three branched chain amino-acids were significantly reduced. Patients with alcoholic fatty liver also showed significantly reduced plasma phenylalanine values. Most changes in plasma amino-acid concentrations in patients with chronic liver disease may be explained on the basis of impaired hepatic function, portal-systemic shunting of blood, and hyperinsulinaemia and http://gut.bmj.com/ hyperglucagonaemia.
    [Show full text]
  • Chapter 3. the Beginnings of Genomic Biology – Molecular
    Chapter 3. The Beginnings of Genomic Biology – Molecular Genetics Contents 3. The beginnings of Genomic Biology – molecular genetics 3.1. DNA is the Genetic Material 3.6.5. Translation initiation, elongation, and termnation 3.2. Watson & Crick – The structure of DNA 3.6.6. Protein Sorting in Eukaryotes 3.3. Chromosome structure 3.7. Regulation of Eukaryotic Gene Expression 3.3.1. Prokaryotic chromosome structure 3.7.1. Transcriptional Control 3.3.2. Eukaryotic chromosome structure 3.7.2. Pre-mRNA Processing Control 3.3.3. Heterochromatin & Euchromatin 3.4. DNA Replication 3.7.3. mRNA Transport from the Nucleus 3.4.1. DNA replication is semiconservative 3.7.4. Translational Control 3.4.2. DNA polymerases 3.7.5. Protein Processing Control 3.4.3. Initiation of replication 3.7.6. Degradation of mRNA Control 3.4.4. DNA replication is semidiscontinuous 3.7.7. Protein Degradation Control 3.4.5. DNA replication in Eukaryotes. 3.8. Signaling and Signal Transduction 3.4.6. Replicating ends of chromosomes 3.8.1. Types of Cellular Signals 3.5. Transcription 3.8.2. Signal Recognition – Sensing the Environment 3.5.1. Cellular RNAs are transcribed from DNA 3.8.3. Signal transduction – Responding to the Environment 3.5.2. RNA polymerases catalyze transcription 3.5.3. Transcription in Prokaryotes 3.5.4. Transcription in Prokaryotes - Polycistronic mRNAs are produced from operons 3.5.5. Beyond Operons – Modification of expression in Prokaryotes 3.5.6. Transcriptions in Eukaryotes 3.5.7. Processing primary transcripts into mature mRNA 3.6. Translation 3.6.1.
    [Show full text]
  • Bicyclomycin Sensitivity and Resistance Affect Rho Factor-Mediated Transcription Termination in the Tna Operon of Escherichia Coli
    JOURNAL OF BACTERIOLOGY, Aug. 1995, p. 4451–4456 Vol. 177, No. 15 0021-9193/95/$04.0010 Copyright 1995, American Society for Microbiology Bicyclomycin Sensitivity and Resistance Affect Rho Factor-Mediated Transcription Termination in the tna Operon of Escherichia coli CHARLES YANOFSKY* AND VIRGINIA HORN Department of Biological Sciences, Stanford University, Stanford, California 94305-5020 Received 13 March 1995/Accepted 27 May 1995 The growth-inhibiting drug bicyclomycin, known to be an inhibitor of Rho factor activity in Escherichia coli, was shown to increase basal level expression of the tryptophanase (tna) operon and to allow growth of a tryptophan auxotroph on indole. The drug also relieved polarity in the trp operon and permitted growth of a trp double nonsense mutant on indole. Nine bicyclomycin-resistant mutants were isolated and partially characterized. Recombination data and genetic and biochemical complementation analyses suggest that five have mutations that affect rho, three have mutations that affect rpoB, and one has a mutation that affects a third locus, near rpoB. Individual mutants showed decreased, normal, or increased basal-level expression of the tna operon. All but one of the resistant mutants displayed greatly increased tna operon expression when grown in the presence of bicyclomycin. The tna operon of the wild-type drug-sensitive parent was also shown to be highly expressed during growth with noninhibitory concentrations of bicyclomycin. These findings demonstrate that resistance to this drug may be acquired by mutations at any one of three loci, two of which appear to be rho and rpoB. Zwiefka et al. (24) found that the antibiotic bicyclomycin segment and interacts with the transcribing RNA polymerase (bicozamycin), an inhibitor of the growth of several gram- molecule, causing it to terminate transcription (7, 9).
    [Show full text]
  • 8.2 Shikimic Acid Pathway
    CHAPTER 8 © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FORAromatic SALE OR DISTRIBUTION and NOT FOR SALE OR DISTRIBUTION Phenolic Compounds © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION CHAPTER OUTLINE Overview Synthesis and Properties of Polyketides 8.1 8.5 Synthesis of Chalcones © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC 8.2 Shikimic Acid Pathway Synthesis of Flavanones and Derivatives NOT FOR SALE ORPhenylalanine DISTRIBUTION and Tyrosine Synthesis NOT FOR SALESynthesis OR DISTRIBUTION and Properties of Flavones Tryptophan Synthesis Synthesis and Properties of Anthocyanidins Synthesis and Properties of Isofl avonoids Phenylpropanoid Pathway 8.3 Examples of Other Plant Polyketide Synthases Synthesis of Trans-Cinnamic Acid Synthesis and Activity of Coumarins Lignin Synthesis Polymerization© Jonesof Monolignols & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC Genetic EngineeringNOT FOR of Lignin SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION Natural Products Derived from the 8.4 Phenylpropanoid Pathway Natural Products from Monolignols © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION 119 © Jones & Bartlett Learning, LLC.
    [Show full text]
  • Pattern of Aromatic and Hydrophobic Amino Acids Critical for One of Two
    Proc. Nati. Acad. Sci. USA Vol. 90, pp. 883-887, February 1993 Biochemistry Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator (transcriptional activation/herpes simplex virus/site-directed mutagenesis/virion protein Vmw65/a-trans-inducing factor) JEFFREY L. REGIER*, FAN SHENt, AND STEVEN J. TRIEZENBERG*t* *Genetics Program and tDepartment of Biochemistry, Michigan State University, East Lansing, MI 48824-1319 Communicated by Steven McKnight, September 29, 1992 (receivedfor review July 14, 1992) ABSTRACT Structural features of the transcriptional ac- tivation domain ofthe herpes simplex virion protein VP16 were I examined by oligonucleotide-directed mutagenesis. Extensive 413 456 490 mutagenesis at position 442 of the truncated VP16 activation Leu Asp Asp Phe Asp LeuAspMet MtAla Asp Phe Glu Phe Glu Gln Met domain (A456), normally occupied by a phenylalanine residue, 439 442 444 473 475 demonstrated the importance ofan aromatic amino acid at that position. On the basis of an alignment of the VP16 sequence FIG. 1. Schematic representation of the VP16 activation domain surrounding Phe-442 and the sequences of other transcrip- (amino acids 413-490). The truncated VP16 activation domain (A456) tional activation domains, we subjected leucine residues at lacks residues 457-490 (24, 31). Portions ofthe amino acid sequence positions 439 and 444 of VP16 to mutagenesis. Results from are shown, using hollow type for hydrophobic amino acids and bold these experiments suggest that bulky hydrophobic residues type for acidic amino acids. flanking Phe-442 also contribute signifucantly to the function of In the case of VP16, the amino-terminal region of the protein the truncated VP16 activation domain.
    [Show full text]
  • Monoamine Biosynthesis Via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom
    Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Torrens-Spence, Michael Patrick et al. "Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom." ACS chemical biology 13 (2018): 3343-3353 © 2018 The Author(s) As Published 10.1021/acschembio.8b00821 Publisher American Chemical Society (ACS) Version Author's final manuscript Citable link https://hdl.handle.net/1721.1/124629 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Articles Cite This: ACS Chem. Biol. XXXX, XXX, XXX−XXX pubs.acs.org/acschemicalbiology Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom † ∇ † ‡ § ∇ † † ∥ Michael Patrick Torrens-Spence, , Chun-Ting Liu, , , , Tomaś̌Pluskal, Yin Kwan Chung, , † ‡ and Jing-Ke Weng*, , † Whitehead Institute for Biomedical Research, 455 Main Street, Cambridge, Massachusetts 02142, United States ‡ Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States § Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States ∥ Division of Life Science, Hong Kong University of Science & Technology, Clear Water Bay, Hong Kong, China *S Supporting Information ABSTRACT: Aromatic L-amino acid decarboxylases (AAADs) are a phylogenetically diverse group of enzymes responsible for the decarboxylation of aromatic amino acid substrates into their corresponding aromatic arylalkylamines. AAADs have been extensively studied in mammals and plants as they catalyze the first step in the production of neurotransmitters and bioactive phytochemicals, respectively.
    [Show full text]
  • I = Chpt 15. Positive and Negative Transcriptional Control at Lac BMB
    BMB 400 Part Four - I = Chpt 15. Positive and Negative Transcriptional Control at lac B M B 400 Part Four: Gene Regulation Section I = Chapter 15 POSITIVE AND NEGATIVE CONTROL SHOWN BY THE lac OPERON OF E. COLI A. Definitions and general comments 1. Operons An operon is a cluster of coordinately regulated genes. It includes structural genes (generally encoding enzymes), regulatory genes (encoding, e.g. activators or repressors) and regulatory sites (such as promoters and operators). 2. Negative versus positive control a. The type of control is defined by the response of the operon when no regulatory protein is present. b. In the case of negative control, the genes in the operon are expressed unless they are switched off by a repressor protein. Thus the operon will be turned on constitutively (the genes will be expressed) when the repressor in inactivated. c. In the case of positive control, the genes are expressed only when an active regulator protein, e.g. an activator, is present. Thus the operon will be turned off when the positive regulatory protein is absent or inactivated. Table 4.1.1. Positive vs. negative control BMB 400 Part Four - I = Chpt 15. Positive and Negative Transcriptional Control at lac 3. Catabolic versus biosynthetic operons a. Catabolic pathways catalyze the breakdown of nutrients (the substrate for the pathway) to generate energy, or more precisely ATP, the energy currency of the cell. In the absence of the substrate, there is no reason for the catabolic enzymes to be present, and the operon encoding them is repressed. In the presence of the substrate, when the enzymes are needed, the operon is induced or de-repressed.
    [Show full text]
  • 4 Aromatic Amino Acids in the Brain M
    4 Aromatic Amino Acids in the Brain M. Cansev . R. J. Wurtman 1 Introduction ..................................................................................... 60 2 Sources of Aromatic Amino Acids .............................................................. 61 3 Plasma Concentrations of the Aromatic Amino Acids . ........................................ 62 3.1 Plasma Tryptophan . .......................................................................... 66 3.1.1 Tryptophan Dioxygenase and Indoleamine Dioxygenase . .................................. 66 3.1.2 Eosinophilia‐Myalgia Syndrome . ................................................................ 69 3.2 Plasma Tyrosine .................................................................................... 69 3.2.1 Tyrosine Aminotransferase . ................................................................ 70 3.3 Plasma Phenylalanine . .......................................................................... 72 3.3.1 Phenylalanine Hydroxylase . ................................................................ 72 4 Brain Tryptophan and Tyrosine ................................................................ 73 4.1 Transport of Plasma Tryptophan and Tyrosine into the Brain . .................................. 74 4.2 Brain Tryptophan . .......................................................................... 75 4.2.1 Tryptophan Hydroxylase . .......................................................................... 77 4.2.2 5‐Hydroxytryptophan and l‐DOPA ...............................................................
    [Show full text]
  • Binds Multiple Sites Within the Aroh and Trp Operators
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Escherichia cod tryptophan repressor binds multiple sites within the aroH and trp operators Andrew A. Kumamoto, ~ William G. Miller, 2 and Robert P. GunsalusL2 1Molecular Biology Institute and the 2Department of Microbiology, University of Califomia, Los Angeles, Califomia 90024 USA DNase I footprinting and methylation protection studies have been used to analyze the binding of Escherichia coli Trp repressor to the trpR, aroH, and trp operators. The methylation protection assay shows that Trp repressor binds in two successive major grooves of the trpR operator, three successive major grooves of the aroH operator, and four successive major grooves of the trp operator. The simplest model that explains the difference in Trp repressor interaction at the three operators is that the aroH and trp operators are composed of multiple, helically stacked binding sites. When viewed in three dimensions, each site is positioned on a different face of the DNA, and together process up the surface of the DNA helix. Analysis of a deletion derivative of the trp operator supports this model. [Key Words" Trp repressor; aroH operator; trp operator; repressor binding] Received February 23, 1987; revised version accepted June 6, 1987. The Trp repressor of Escherichia coli coordinately regu- and by the isolation of constitutive mutations within lates the expression of the trp, aroH, and trpR operons in the trp operator {Bennett and Yanofsky 1978). These op- response to the intracellular levels of L-tryptophan erator constitutive mutations map at positions -16, (Cohen and Jacob 1959; Brown 1968; Rose et al.
    [Show full text]